Literature DB >> 2831664

Identification of the simian rotavirus SA11 genome segment 3 product.

M Liu1, P A Offit, M K Estes.   

Abstract

Previous studies on rotavirus gene-coding assignments failed to clearly identify the simian rotavirus SA11 genome segment 3 protein product. This question was reexamined by using new conditions of electrophoresis with improved resolution of proteins in the high-molecular-weight range. Our results showed that the SA11 genome segment 3 codes for a protein with an apparent mol wt of 88,000. This protein normally comigrates with the protein product of genome segment 4. The gene 3 protein was located in viral core particles by comparing the electrophoretic patterns of [35S]methionine-labeled viral polypeptides from infected cells and from purified double-shelled, single-shelled, and core particles. To confirm the identity of the gene 3 product, we also studied two reassortant viruses in which genome segment 3 was reassorted from each of two parental virus strains (SA11 and NCDV). The gene 3 and gene 4 products of these viruses were identified by (i) their separation by two different polyacrylamide gel systems, (ii) their location in distinct particle types, (iii) their differential sensitivity to trypsin digestion, and (iv) their distinctive protease peptide maps. We propose that the genome segment 3 product be called VP3 and that the gene 4 product be named VP4 from now on.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831664     DOI: 10.1016/0042-6822(88)90230-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Expression of the major capsid protein VP6 of group C rotavirus and synthesis of chimeric single-shelled particles by using recombinant baculoviruses.

Authors:  G Tosser; M Labbé; M Brémont; J Cohen
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Effect of intragenic rearrangement and changes in the 3' consensus sequence on NSP1 expression and rotavirus replication.

Authors:  J T Patton; Z Taraporewala; D Chen; V Chizhikov; M Jones; A Elhelu; M Collins; K Kearney; M Wagner; Y Hoshino; V Gouvea
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Development, characterization, and diagnostic applications of monoclonal antibodies against bovine rotavirus.

Authors:  Y Al-Yousif; F Al-Majhdi; C Chard-Bergstrom; J Anderson; S Kapil
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

4.  Rotavirus spike structure and polypeptide composition.

Authors:  I D Anthony; S Bullivant; S Dayal; A R Bellamy; J A Berriman
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Rotavirus protein rearrangements in purified membrane-enveloped intermediate particles.

Authors:  M S Poruchynsky; P H Atkinson
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Inhibition of in vitro reconstitution of rotavirus transcriptionally active particles by anti-VP6 monoclonal antibodies.

Authors:  E Kohli; P Pothier; G Tosser; J Cohen; A M Sandino; E Spencer
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  Rotavirus RNA replication: VP2, but not VP6, is necessary for viral replicase activity.

Authors:  E A Mansell; J T Patton
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Subgroup and serotype distributions of human, bovine, and porcine rotavirus in Thailand.

Authors:  Y Pongsuwanne; K Taniguchi; M Choonthanom; M Chiwakul; T Susansook; S Saguanwongse; C Jayavasu; S Urasawa
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

9.  Serological characterization of bovine rotaviruses isolated from dairy and beef herds in Argentina.

Authors:  R C Bellinzoni; J O Blackhall; N M Mattion; M K Estes; D R Snodgrass; J L LaTorre; E A Scodeller
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

10.  The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.

Authors:  M Lizano; S López; C F Arias
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.